Hair loss is among the side effects of chemotherapy which are not only quite visible but also extremely distressing at the emotional level. Through discussions of cancer rounds and survivorship, it has been found that patients narrate chemotherapy, induced hair loss as a concern way beyond the mere cosmetic factor. The sudden and often inevitable loss of hair can deeply damage a patients perception of identity, dignity, and self, image, as it becomes a constant and public reminder of the illness. For the majority, it affects how they interact socially, their relationships, their ability to comfortably work, and their emotional strength, and it may even result in anxiety, depression, or social isolation despite the treatment being successful.
Supportive care strategies aimed at preserving the quality of life thus come to play a role in a modern oncology practice. Scalp cooling therapy has been introduced as a scientifically grounded, evidence, supported intervention to reduce chemotherapy, related hair loss in cancer patients, particularly those with solid tumors undergoing such treatment. Although it does not completely get rid of alopecia, scalp cooling still can go a long way in minimizing its severity, thus helping patients keep their psychological well, being and their sense of normalcy during a cancer treatment period which is emotionally and physically very challenging.
Why Does Chemotherapy Cause Hair Loss?
Chemotherapy operates by attacking rapidly dividing cells, which is a characteristic feature of cancerous tissue. Although this property is a crucial aspect of cancer treatment, the action is not limited to the tumor cells only. Normal tissues capable of frequent cell division are also affected; the most obvious example is the hair follicle matrix keratinocytes, which are among the human cells with the fastest rate of proliferation.
Chemotherapy results in damage to hair follicles, which later manifests as the signs and symptoms of chemotherapy, induced alopecia, including the following:
- Prompt anagen hair shedding as a consequence of direct harm to follicles that are in the active growth phase
- Partial or total hair loss, which is influenced by the chemotherapy regimen and the patient’s individual predisposition
- Changes in hair quality, coarseness, and color are commonly observed during the process of regrowth
It has been established that the first clinical signs of hair loss occur usually 2, 4 weeks after chemotherapy commencement, which is the period when the total damage inflicted on the hair follicles by the treatment becomes apparent. In numerous cases, alopecia is one of the signs that the patient manifests during the whole period of treatment and even after the therapy completion for several months, whereas with the restoration of the normal follicular function, hair regrowth will eventually take place.
5 easy Steps to Get Treated Abroad
Share Case Details
Get Expert Opinion and Hospital Quotes
Get Visa Invitation & Hotel Recommendations
Get Received At Airport and Start Your Treatment
Travel Back and Get Followups Through Us
Chat on WhatsAppDrug type, dose intensity, duration of treatment as well as patient, related factors determine the degree of hair loss and its recoverability.
How Does Scalp Cooling Work? (Cancer Rounds Perspective)
Cool cap chemo,” also known as scalp cooling, involves the use of a temperature-controlled cooling cap worn before, during, and after chemotherapy infusion
Mechanisms of Action
Scalp cooling works via two primary mechanisms:
- Vasoconstriction
- Reduced scalp blood flow
- Decreased delivery of chemotherapeutic agents to hair follicles
- Reduced Cellular Uptake
- Lower follicular metabolic activity
- Reduced chemotherapy absorption by follicular cells
Target scalp temperature is typically maintained between 18–22°C (64–72°F).
This dual mechanism helps preserve follicular integrity, thereby reducing the severity of hair loss.
Types of Scalp Cooling Caps (Material & Technology)
1. Machine-Based Cooling Systems (Most Effective)
Material
- Medical-grade silicone or polyurethane cap
- Integrated circulating coolant system
Common Systems
- DigniCap®
- Paxman®
Features
- Precise temperature control
- Consistent cooling throughout infusion
- FDA-approved
2. Manual Gel-Based Cooling Caps
Material
- Gel-filled caps (silicone or neoprene exterior)
- Pre-frozen at −25°C to −30°C
Features
- Requires multiple cap changes every 20–30 minutes
- Less precise temperature control
- Higher variability in outcomes
Used more commonly in resource-limited settings
Who May Benefit from Scalp Cooling?
Based on oncology guidelines and institutional cancer rounds:
Scalp cooling may be considered for:
- Early-stage breast cancer
- Gynecological cancers
- Colorectal cancer
- Prostate cancer
- Other solid tumors on non-alopecia-intensive regimens
Eligibility depends on:
- Chemotherapy type and dose
- Duration of treatment
- Absence of scalp involvement
- Patient tolerance to cold
Who Should NOT Use Scalp Cooling?
Scalp cooling is contraindicated or not recommended in patients with:
- Hematological malignancies (leukemia, lymphoma, multiple myeloma)
- Scalp metastasis or suspected scalp involvement
- Primary scalp skin cancers
- CNS tumors
- Head and neck cancers
- Small-cell lung carcinoma
- Cold sensitivity disorders (e.g., cold agglutinin disease, cryoglobulinemia)
- Severe hepatic or renal impairment
- Concurrent cranial radiation therapy
- Bone marrow ablation chemotherapy
Safety remains the top priority.
How Effective Is Scalp Cooling?
From clinical trials and post-FDA approval data discussed in cancer rounds:
- Average hair preservation: ~50–70%
- Complete hair retention is uncommon
- Results vary widely between individuals
Effectiveness depends on:
- Chemotherapy regimen (taxanes respond better than anthracyclines)
- Drug dosage
- Duration of post-cooling
- Patient age and hair characteristics
FDA approval for scalp cooling systems was granted in 2015, and long-term oncologic safety data remain reassuring.
Side Effects of Scalp Cooling
Most side effects are temporary and manageable:
- Chills
- Headache
- Scalp pressure or tightness
- Dizziness
- Nausea
- Sinus discomfort
- Numbness or tingling
Symptoms are most intense during the initial 15–30 minutes of cooling.
Cost of Scalp Cooling – India & Global
India (Approximate)
| Type | Cost per Session | Total Course |
| Machine-based systems | ₹5,000–₹10,000 | ₹50,000–₹1,20,000 |
| Gel-based manual caps | ₹2,000–₹4,000 | ₹25,000–₹60,000 |
International (USD)
- $300–$600 per session
- Total course: $2,000–$4,500
Insurance coverage in India is limited, though select corporate policies and hospital packages may offer partial coverage.
Availability in India
Scalp cooling is currently available in:
- Tertiary cancer centers
- Corporate oncology hospitals
- Selected private chemotherapy infusion units
Availability varies by city and institution.
What Happens During a Scalp Cooling Session?
- Hair Preparation
- Hair is dampened
- Conditioner applied
- Hair gently combed back
- Pre-Cooling
- Begins 30 minutes before chemotherapy
- During Chemotherapy
- Cooling continues throughout infusion
- Post-Cooling
- Continues for 60–90 minutes after infusion
Total session time increases by 1.5–2 hours.
FAQ – Scalp Cooling Therapy
Q.1 Will scalp cooling completely prevent hair loss?
No. It reduces severity but does not guarantee full hair preservation.
Q.2 Is scalp cooling safe from an oncologic perspective?
Current evidence shows no increased risk of scalp metastasis in eligible patients.
Q.3 Does scalp cooling work for all chemotherapy drugs?
It works best with taxane-based regimens and less effectively with anthracyclines.
Q.4 Can men use scalp cooling?
Yes, eligibility depends on cancer type and chemotherapy regimen.
Q.5 Is hair regrowth normal after scalp cooling?
Yes. Regrowth is often faster and more uniform.
Q.6 Can I color or chemically treat my hair during therapy?
No. Hair should be handled gently—no coloring, perming, or heat styling.
Q.7 Is it painful?
It can be uncomfortable initially but is usually tolerable.
Q.8 Does scalp cooling affect chemotherapy effectiveness?
No evidence suggests reduced systemic chemotherapy efficacy.
Q.9 Can scalp cooling be stopped mid-treatment?
Yes, if poorly tolerated or ineffective.
Q.10 Should everyone undergoing chemotherapy try scalp cooling?
No. It should be offered selectively after oncology consultation.
Final Thoughts – Cancer Rounds Perspective
Scalp cooling is not a cosmetic luxury, but a quality-of-life intervention that can significantly improve emotional well-being for selected patients undergoing chemotherapy. While it does not eliminate hair loss entirely, even partial preservation can restore confidence and normalcy during treatment. Patients considering scalp cooling should engage in a shared decision-making discussion with their oncology care team, balancing safety, cost, comfort, and expected benefit.
